A Strategic Blueprint: Differentiating Generics and Biosimilars for Competitive Advantage
In the fiercely competitive landscape of pharmaceuticals, differentiation isn’t just a strategic advantage—it’s a necessity. As the industry evolves, companies are grappling with a complex maze of regulations, patent cliffs, and market expectations. Th…
